ROTOP Pharmaka GmbH specializes in the development and production of innovative pharmaceutical products, particularly in the field of radiopharmaceuticals. The company employs advanced technologies for the synthesis and formulation of these products, ensuring high quality and efficacy. Their expertise includes the use of targeted radiotherapy, which allows for precise delivery of therapeutic agents to cancerous tissues, minimizing damage to surrounding healthy cells. This approach is complemented by their commitment to research and development, focusing on enhancing the safety and effectiveness of their offerings.

In addition to their radiopharmaceuticals, ROTOP Pharmaka GmbH utilizes cutting-edge manufacturing processes that adhere to stringent regulatory standards. Their facilities are equipped with state-of-the-art technology for the production of sterile and non-sterile products, ensuring compliance with Good Manufacturing Practices (GMP). The company also emphasizes the importance of continuous innovation, investing in new methodologies and technologies to improve their product pipeline and expand their therapeutic applications. This dedication to scientific advancement positions ROTOP Pharmaka as a leader in the pharmaceutical industry, particularly in the niche of radiopharmaceuticals.

Germany

ROTOP Pharmaka is a leading German pharmaceutical company that produces cGMP compliant radiopharmaceuticals for diagnostics and therapy in Nuclear Medicine and Molecular Imaging and distributes them in more than 30 countries worldwide. With almost 20 years of experience in the development, production, authorization and distribution of sterile kits for radiolabeled pharmaceuticals ROTOP continuously expands its product portfolio by developing new products and entering new strategic partnerships.

ROTOP Pharmaka GmbH

Company Details